MedTrace Logo

Efficacy of OsteoBor in Postmenopausal Osteoporosis

NCT06809816 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-02-05

No results posted yet for this study

Summary

This study aims to evaluate the impact of boron supplementation (OsteoBor) on bone health in postmenopausal women. The trial is a phase 2, randomised, double-blind, placebo-controlled study lasting one year

Conditions

  • Osteoporosis, Postmenopausal

Interventions

DRUG

Sodium pentaborate pentahydrate

Sodium pentaborate pentahydrate will be administered orally in capsule form, following the standard protocol outlined in the study design.

Sponsors & Collaborators

  • Tabriz University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2025-08-01
Completion
2025-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06809816 on ClinicalTrials.gov